Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06538610 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The 5-FU Holter Study

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 9, 2024 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Primary completion date: Jan 2025 to Jul 2025
    • Start date changed from estimate of Oct 2024 to Nov 1, 2024
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To assess the feasibility of using ambulatory ECG monitoring (Holter monitor) for patients receiving 5-FU chemotherapy
Trial Details
NCT Number NCT06538610
Lead Sponsor University of Auckland, New Zealand
Collaborators: Gut Cancer Foundation, Auckland City Hospital, The Heart Group
Conditions
(from sponsor)		 Gastrointestinal Malignancy
Enrollment 10 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov